With a market size of $47 billion in Canada alone, the pharmaceutical industry is one of the largest in the country. When it comes to valuing pharmacies, it is of the utmost importance to understand the unique business challenges they face as a significant number are franchisees of large pharmacy chains. There are specific adjustments required in order to determine their fair market value. Join Ariane Babin (Partner, MNP) and Christopher Crofoot (National Director Healthcare, CIBC Corporate Finance) as they dive into the main EBITDA adjustments needed to obtain an appropriate measure of the enterprise’s representative cash flow. They will also explore the main challenges the industry faces all over the country that makes them unique to value.

The information, analysis and opinions expressed in the webinars, podcasts and/or congress presentations are solely those of the presenter/author, are not reviewed by the Institute as to content or accuracy, and are not endorsed by CBV Institute or any of its Members.